Portopulmonary hypertension: state of the art

Journal Title: Annals of Hepatology - Year 2008, Vol 7, Issue 4

Abstract

Portopulmonary hypertension is an uncommon but treatable pulmonary vascular consequence of portal hypertension, which can lead to significant morbidity and mortality. Portopulmonary hypertension results from excessive pulmonary vasoconstriction and vascular remodeling that eventually leads to right-heart failure and death if left untreated. Although pulmonary vascular disease in these patients may be asymptomatic or associated with subtle and nonspecific symptoms (dyspnea, fatigue and lower extremity swelling), it should be looked for especially if patients are potential candidates for liver transplantation. Patients with clinical suspicion of portopulmonary hypertension should undergo screening testing, specifically echocardiography. Right heart catheterization remains the gold standard for the diagnosis. The existence of moderate to severe disease poses higher risks and challenges for liver transplantation. The disease has a substantial impact on survival and requires focused pharmacological therapy. New and evolving medical therapies, such as prostanoids (intravenous, inhaled or oral), endothelin receptors antagonists, phosphodiesterases inhibitors, combination therapy and other experimental drugs might change the natural course of the disease. Case reports and cases series have been published regarding the efficacy and safety of pharmacological therapy, but randomized, controlled multicenter trials are urgently needed. Liver transplantation is not the treatment of choice for portopulmonary hypertension, but after optimal hemodynamic and clinical improvement with medical therapy as a bridge, liver transplant can be considered an option in selected patients.

Authors and Affiliations

Mateo Porres-Aguilar, Marc Zuckerman, Juan Figueroa-Casas, Michael Krowka

Keywords

Related Articles

Hepatoprotective effect of pentoxifylline against D-galactosamine-induced hepatotoxicity in rats

The present study was conducted to investigate effect of pentoxifylline (PTX) on acute liver injury caused by galactosamine (D-Gal) in rats and the underlying mechanism involved in this setting. Moreover, we attempted to...

Region 11 MELD Na exception prospective study

Introduction. Hyponatremia complicates cirrhosis and predicts short term mortality, including adverse outcomes before and after liver transplantation. Material and methods. From April 1, 2008, through April 2, 2010, all...

Hepatic hydrothorax: Current concepts of pathophysiology and treatment options

Pleural effusions develop in 6-10% of patients with end-stage liver disease. Although, commonly seen in conjunction with ascites, isolated hepatic hydrothorax can occur in a small number of patients with cirrhosis. Refra...

Recurrent idiopathic acute hepatitis-associated aplastic anemia/pancytopenia fourteen years after initial episo

Aplastic anemia following viral hepatitis is a condition well recognized in the medical literature. Although hepatitis-associated aplastic anemia is an uncommon syndrome, there are several reports in the literature descr...

Download PDF file
  • EP ID EP77805
  • DOI -
  • Views 156
  • Downloads 0

How To Cite

Mateo Porres-Aguilar, Marc Zuckerman, Juan Figueroa-Casas, Michael Krowka (2008). Portopulmonary hypertension: state of the art. Annals of Hepatology, 7(4), 321-330. https://europub.co.uk./articles/-A-77805